IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q4 2013 Holdings

Filed 2014-02-14 | 14 holdings | $198.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Medivation, Inc.Com58501N101$158.5K2,484,10179.8%
Ampio Pharmaceuticals Inc.Com03209T109$14.5K2,026,9987.3%
Alcobra LtdSHSM2239P109$12.4K687,0006.2%
Keryx Biopharmaceuticals Inc.Com492515101$2.6K200,0001.3%
Sequenom Inc.Com New817337405$2.1K893,6001.0%
Synthetic Biologics Inc.COM87164U102$2.1K1,360,0001.0%
Newlink Genetics CorpCom651511107$1.7K77,4370.9%
Inovio Pharmaceuticals Inc.CPM45773H102$1.2K408,3520.6%
Vivus Inc.CallCall928551900$1.1K5,0000.5%
Advaxis Inc.COM NEW7624208$947225,0000.5%
Parkervision Inc.COM701354102$910200,0000.5%
Merrimack Pharmaceuticals Inc.COM590328100$40075,0000.2%
Advaxis Inc.W EXP 07/15/2017624117$186112,5000.1%
Echo Therapeutics Inc.Com New27876L206$14044,4450.1%